XSTO
ATORX
Market cap666kUSD
, Last price
SEK
Name
Alligator Bioscience AB
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Allego N.V. functions as a dedicated provider of electric vehicle (EV) charging infrastructure and services, addressing the needs of drivers across various segments, including passenger cars, buses, and trucks. The company establishes, owns, and manages a comprehensive network of charging ports. Beyond its physical infrastructure, Allego delivers a full suite of EV-related services. These encompass initial site planning and technical layout, streamlined authorization and billing processes, and continuous operational support and maintenance. These services are designed for a diverse clientele, such as corporate fleets, property owners hosting charging stations, original equipment manufacturers (OEMs), and municipal entities. Notably, Allego's charging network integrates renewable energy sources. The company also crafts bespoke charging solutions for its business clients, fostering partnerships with prominent retail and automotive brands. Its operations further include the sale and installation of charging hardware, the direct supply of electricity to EV users, and the ongoing maintenance of charging equipment, in addition to offering expert consulting services. A significant technological offering is the Allego EV Cloud, a robust software platform that provides advanced functionalities like seamless charging authorization, intelligent billing, smart charging and load balancing capabilities, analytical insights, and dedicated customer support. Established in 2013, Allego N.V. is headquartered in Arnhem, the Netherlands, and operates as a subsidiary of Madeleine Charging B.V.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||